Among the different types of thyroid cancer, one particular type stands out as the most common and frequently diagnosed: papillary thyroid cancer. This comprehensive exploration will delve into the ...

It’s very helpful, Robin Clough said, when, in the midst of a life-threatening medical crisis, the person you live with is a ...

In a new analysis of genetic susceptibility to kidney cancer, an international team of researchers has identified 50 new ...

Patients with Bacillus Calmette-Guérin-unresponsive non-muscle-invasive bladder cancer carcinoma in situ now have a new ...

The U.S. Food and Drug Administration (FDA) has approved the immunotherapy-boosting drug N-803, which is marketed under the ...

FDA approves immunotherapy drug combo for non-muscle invasive bladder cancer after UCLA-led research shows improved outcomes ...

The US Food and Drug Administration (FDA) has granted approval for ImmunityBio's ANKTIVA, plus Bacillus Calmette-Guérin (BCG), for treating patients with BCG-unresponsive non-muscle invasive bladder ...

ImmunityBio has yet to finalize a registrational trial plan with the FDA in that papillary disease population, Soon-Shiong ...

ImmunityBio, Inc. (NASDAQ: IBRX), an immunotherapy company, today announced that the U.S. Food and Drug Administration (FDA) ...

ImmunityBio finally received FDA approval for its drug ANKTIVA for the treatment of patients with BCG-unresponsive NMIBC with ...

A first-in-class interleukin (IL)-15 receptor agonist, the drug is specifically approved in combination with BCG for adults ...

Robin Clough and Dr. Gene Dorio were going about their lives as they had for many years, serving older adults in Southern California. Clough was busy with her work as an administrator at the local ...